A new era has arrived for CsA, with the powerful combination of a higher concentration offered in conjunction with advanced drug delivery technology. This important clinical development is giving eye care practitioners another tool to help manage the chronic and inflammatory nature of DED for their patients.
This supplement is based on a Medscape Education online activity and discusses how to identify signs of diabetic eye disease along with screening and monitoring recommendations. It also addresses the gaps in disease management that exist today.
Supported by an independent educational grant from Regeneron